] ϭ 24 ϫ PaCO 2 /[HCO 3 Ϫ ]. 1 The four canonical acidbase disorders include the respiratory disorders (acidosis and alkalosis) and the metabolic disorders (acidosis and alkalosis). Whereas the respiratory disorders are expressed as primary changes in PaCO 2 , the metabolic disorders are expressed as primary changes in plasma [HCO 3 Ϫ ]. 2, 3 Each primary change in either the respiratory or the metabolic component elicits in vivo a secondary response in the countervailing component that is directional and proportional to the primary change, albeit fractionally smaller, thus tending to minimize the change in body acidity. These secondary responses originate from physicochemical buffering and change in ventilation, organic-acid metabolism, and renal acidification. They have been quantified in dogs and humans, are consistent in presence and predictable in magnitude, and are viewed as an integral part of each canonical disorder. Absence of an appropriate secondary response denotes the coexistence of an additional acid-base disturbance. [1] [2] [3] A popular, alternative epithet of the secondary responses is compensatory. We discourage use of this term, because it evokes confusing pronouncements about partial versus complete compensation; secondary responses generally ameliorate the impact of primary changes on blood acidity but never completely restore blood acidity to control levels. Moreover, under certain circumstances, secondary responses yield a maladaptive effect on blood pH (see next section). 1, 3 We term the secondary responses to respiratory acidosis (primary increase in PaCO 2 ) and respiratory alkalosis (primary decrease in PaCO 2 ) secondary hyperbicarbonatemia and secondary hypobicarbonatemia, respectively. The alternative terms secondary or compensatory metabolic alkalosis and secondary or compensatory metabolic acidosis, respectively, are also confusing and objectionable. Similarly, the secondary responses to metabolic acidosis (primary decrease in plasma [HCO 3 Ϫ ]) and metabolic alkalosis (primary increase in plasma [HCO 3 Ϫ ]) are termed secondary hypocapnia and secondary hypercapnia, respectively; we discourage use of the alternative terms secondary or compensatory respiratory alkalosis and secondary or compensatory respiratory acidosis, respectively. 3 
MAGNITUDE AND TIME COURSE OF THE SECONDARY RESPONSES
Here we examine the mean slope of the secondary response to each cardinal acidbase disorder (Table 1) 4 An essentially identical slope is obtained in humans in whom respiratory acidosis is induced by endogenous hypercapnia. 5 Sustained hypercapnia causes an additional, larger increase in plasma [HCO 3 Ϫ ] owing to stimulation of renal acidification. In dogs, a new steady state emerges within 3 to 5 days. 6, 7 Whether this temporal pattern applies to humans is unknown. In patients, chronic hypercapnia often reflects gradual deterioration in pulmonary function; consequently, the secondary response might keep pace with the slowly rising PaCO 2 without a perceptible delay. Careful observations of patients with chronic hypercapnia as a result of chronic obstructive pulmonary disease allowed estimation of a mean ⌬[HCO ]/ ⌬PaCO 2 seems to flatten. 8, 9 More recently, a substantially larger slope was reported, but the small number of blood gas measurements, one for each of 18 patients, calls into question the validity of the conclusion reached. 10 
Respiratory Alkalosis
Hypocapnia alkalinizes body fluids and titrates nonbicarbonate buffers, yielding a decrease in plasma [HCO 3 Ϫ ]. This secondary hypobicarbonatemic response is completed within 5 to 10 minutes and remains stable for several hours. Hypocapnia of 20 to 120 minutes' duration resulting from either voluntary hyperventilation in normal individuals or controlled hyperventilation in anesthetized patients undergoing minor surgical procedures yielded a mean 11, 12 Sustained hypocapnia causes an additional decrease in plasma [HCO 3 Ϫ ] owing to suppression of renal acidification. A new steady state emerges within 2 to 3 days. 13, 14 Studies of normal volunteers who were exposed to hypobaric hypoxia (6 days) and unanesthetized patients who had spinal cord or head injuries and were undergoing controlled hyperventilation ( 16 -20 The secondary response appears within 30 to 120 minutes from onset of metabolic acidosis; the time interval for its completion (and its disappearance after correction of the metabolic acidosis) depends on the pace of development of the disorder. 21, 22 In patients with cholera, when plasma [HCO 3 Ϫ ] falls or corrects slowly, such as by 6 mEq/L in 24 hours, the ventilatory response keeps pace with the level of plasma [HCO 3 Ϫ ]. Conversely, when metabolic acidosis develops or corrects rapidly, 11 to 24 hours is required for the ventilatory response to reach completion or vanish. 16 
Metabolic Alkalosis
Contrary to the wide recognition of metabolic acidosis-induced secondary hypocapnia, the very existence of secondary hypercapnia in response to metabolic alkalosis is controversial. 23, 24 Absence of hypercapnia in some early studies can be traced to methodologic problems and inclusion of patients who have disorders that stimulate ventilation. 23 In addition, confusion arises from the seemingly paradoxic stimulation of ventilation observed during rapid intravenous infusion of sodium bicarbonate, a model of acute metabolic alkalosis; this hyperventilatory response, caused by decomposition of bicarbonate into CO 2 , is short-lived and converts to alkalemia-induced hypoventilation. 25 Subsequent studies established that the alkalemia engendered by metabolic alkalosis consistently suppresses alveolar ventilation, an effect primarily caused by 23, 26 Contrary to early views, neither hypoxemia nor potassium depletion prevents expression of this response. The requisite time for development of the secondary hypercapnia remains uncertain. Although studies indicate that full expression of the hypoventilatory response requires 24 to 36 hours, such a lag might not occur in patients who develop metabolic alkalosis at a slow pace.
CAVEATS
In assessing the appropriateness of the secondary response to an acid-base disorder, there are several caveats.
Time Course
As noted, considerable uncertainty exists regarding the time course for completion and eradication of the secondary responses in humans. A mixed acid-base disorder might be diagnosed incorrectly because insufficient time has elapsed for the secondary response to a single primary disorder to develop or resolve. 3 
Confidence Intervals
Empirical data have been used to construct confidence intervals that define the limits of the secondary response to each acid-base disorder. In clinical practice, these limits can be taken as Ϯ3 mEq/L for plasma [HCO 3 Ϫ ] and Ϯ5 mmHg for PaCO 2 from the values calculated from the mean, steady-state slopes (Table 1) . 3 Values falling outside these limits denote the presence of a mixed acidbase disorder. Importantly, values falling within the limits of the secondary response can be interpreted as consistent with but not diagnostic of a particular disorder. In fact, a given set of acid-base values is never diagnostic of a specific acidbase disorder; clinical correlation is always required to establish the correct diagnosis. Interpretation of acid-base data of patients undergoing ventilator support must consider that this procedure sets the PaCO 2 level and thus has the potential of altering preexisting acid-base status, whether normal or abnormal. 1 
Impact of Preexisting Acid-Base Disorders
Clinicians tend to apply equally the slopes depicted in Table 1 to patients presumed to have a single acid-base disorder and those with mixed disorders. This practice assumes preexisting acid-base disorders do not influence the secondary response to superimposed disorders. Extensive studies of the dog demonstrate this supposition is largely erroneous. The ⌬[HCO 3 Ϫ ]/⌬PaCO 2 response to acute hypercapnia in dogs with background metabolic acidosis or chronic respiratory alkalosis is larger than that in normal animals, whereas this response is smaller than normal in dogs with preexisting metabolic alkalosis or chronic respiratory acidosis. 27, 28 Similarly, the ⌬[HCO 3 Ϫ ]/ ⌬PaCO 2 response to chronic respiratory acidosis is larger in dogs with underlying metabolic acidosis and smaller in those with background metabolic alkalosis than in normal dogs. 29, 30 Normal dogs and dogs with background metabolic acidosis have an identical secondary response to chronic hypocapnia, but this response is much larger in dogs with underlying metabolic alkalosis. 13, 31, 32 It is highly probable but still unknown whether humans exhibit a similar response to that demonstrated in dogs. Consequently, the direct applicability of the slopes depicted in Table 1 Figure 1 . Pathophysiologic basis of the change in plasma [HCO 3 Ϫ ] in metabolic acidosis (left) and metabolic alkalosis (right) in the dog. Only a part of the change in plasma [HCO 3 Ϫ ] is attributed to the primary metabolic process. The remainder, approximately 40% of the overall change, is due to adjustments in renal acidification engendered by the associated secondary hypocapnia or hypercapnia. These renal responses are maladaptive because they undermine the salutary effect on blood pH afforded by the ventilatory responses acutely. Based on data from Madias and colleagues. 30, 33 secondary hypocapnia or hypercapnia. Indeed, fully 40% of the overall change in plasma [HCO 3 Ϫ ] in metabolic disorders results not from the metabolic processes themselves, particularly the acid load in metabolic acidosis or volume and Cl Ϫ deficits in metabolic alkalosis, but from the indiscriminant responses of the kidney to secondary changes in PaCO 2 ( Figure 1) . 30, 33 These renal responses are maladaptive because they undermine the salutary effect on blood pH afforded by the ventilatory responses acutely. Indeed, under certain conditions, this maladaptation nullifies a beneficial impact or even yields a more abnormal pH than would occur in the complete absence of a ventilatory response. The similarity of the acidification processes between dogs and humans suggests strongly that these observations are also applicable to humans; however, until the requisite studies are carried out, such extrapolations must remain conjectural.
